Numerous human cancers exhibit resistance to PD-1 antibodies, often characterized by a notable absence of CD8+ T cell infiltration, resulting in ‘cold’ tumors.35 These tumors lack the immunogenicity needed to trigger a spontaneous T cell response that checkpoint blockade could amplify. The gene discussed is CD8A; the disease is cancer.